Visão geral da empresa Codexis
1 escritórioLocalizações
Our mission is to to transform the enzyme engineering landscape for the betterment of human health!
We as a company pride ourselves on the commitment to human health. We are committed to human health and quality of life, and we work diligently to enhance life science tools for genomic research, enable molecular diagnostic innovations, and develop better biotherapeutics such as oral biologics. In addition, we support the rare disease community through actions, and correspond directly with patients, clinicians, and advocacy leaders to ensure that our innovations can address patient needs.
We as a company pride ourselves on the commitment to human health. We are committed to human health and quality of life, and we work diligently to enhance life science tools for genomic research, enable molecular diagnostic innovations, and develop better biotherapeutics such as oral biologics. In addition, we support the rare disease community through actions, and correspond directly with patients, clinicians, and advocacy leaders to ensure that our innovations can address patient needs.
At Codexis, we engineer enzymes for biosolutions that benefit human health and environmental health. From developing biocatalysts for sustainable pharmaceutical manufacturing, to engineering enzymes for effective disease treatments and accurate molecular diagnostics, we aim to create a brighter future. This unified vision is what drives us to challenge what is possible.
Since the start of the company in 2002, Codexis has partnered with established and emerging companies. We continue to offer many research and development partnership options to develop and deliver quality engineered solutions and provide a path to successful commercialization. This is carried out through a highly engaged and collaborative approach.
Reimagine enzymes as enablers for efficient pharmaceutical manufacturing, sequencing and diagnostic applications, RNA manufacturing and more. Engineered enzymes can overcome current challenges, bottlenecks and enable new methods for product and process innovations.
Since the start of the company in 2002, Codexis has partnered with established and emerging companies. We continue to offer many research and development partnership options to develop and deliver quality engineered solutions and provide a path to successful commercialization. This is carried out through a highly engaged and collaborative approach.
Reimagine enzymes as enablers for efficient pharmaceutical manufacturing, sequencing and diagnostic applications, RNA manufacturing and more. Engineered enzymes can overcome current challenges, bottlenecks and enable new methods for product and process innovations.
